Speakers

Sylvia Baedorf Kassis

Program Manager

Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, USA

Raquel Billiones

Associate Director, Medical Writing

Alexion Pharmaceuticals, Switzerland

Iwona Bucior

Sr. Director, Medical Affairs

Bristol Myers Squibb, USA

Donell Carey

Clinical Trial Results Lead

Bristol Myers Squibb, USA

Deborah Collyar

President

Patient Advocates In Research (PAIR), USA

Lisa DeTora

Professor Assistant

Hofstra University, USA

Nicholas DeVito

DPhil Candidate and Researcher

University of Oxford, UK

Cathal Gallagher

Senior Life Sciences Consultant

d-wise, USA

Andrew George

non-executive Board member

Health Research Authority, UK

Debra Guerreiro

Plain Language Summary Program Lead, Data Transparency, Integrated Data Analytics and Reporting (IDAR), Global Development

Janssen R&D, USA

Anne-Marie Hamoir

Senior Consultant

Patient Focused Medicines Development (PFMD), the Synergist, Brussels

Joyce Hauze

Associate Director, Clinical Trial Disclosure and Transparency

Mallinckrodt Pharmaceuticals, USA

Julie Holtzople

Head of Clinical Transparency and Data Sharing

AstraZeneca, USA

Amanda Hunn

Principal

l, A J Hunn Associates

Merete Joergensen

Senior Director, Clinical Transparency

Novo Nordisk, Denmark

Maureen Mooney Kashuba

Plain Language Summary Project Lead

Merck & Co., Inc, USA.

Anthony Keyes

Director

Johns Hopkins ClinicalTrials.gov Program and co-chair of the Clinical Trials Registration and Results Reporting Taskforce, USA

Lora Killian

Transparency and Disclosure Lead

Pfizer, USA

Ingrid Klingmann

Chairman

European Forum for Good Clinical Practice (EFGCP), Belgium

Rebecca Li

Executive Director

Vivli, USA

Kristin McDougall,

Director of Transparency

d-wise, USA

Jill McNair

Senior Director, Health Communication Services

Center for Information & Study on Clinical Research Participation (CISCRP), USA

Jennifer Miller

Founder, Bioethics International and the Good Pharma Scorecard, Assistant Professor

Yale University School of Medicine, USA

Caragh Murray

Plain Language Summary Program Manager

The Janssen Pharmaceutical Companies of Johnson & Johnson, USA

Oladayo Oyelola, PhD, SC (ASCP)

Senior Director, Clinical Trial Information Disclosure, Regulatory Management Operations

Daiichi Sankyo, Inc., USA

Liz Roberts

Global Public Policy Lead, External Engagement Practice

UCB, USA

Alexander Roussanov

International Partner

Arnold & Porter, Belgium

Thomas Schindler

Innovation Medical Writing

Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

Sonia A. Schweers

Publication Compliance Lead, WW Medical Compliance & Governance, Medical Capabilities

Bristol Myers Squibb, USA

Theresa Shalaby

Senior Regulatory Services Manager

Synchrogenix, a Certara company, USA

Laura Sheppard

Director of Medical Writing, R&D Operations

Endo, USA

Lars Taavola

Vice President, Chief Intellectual Property Counsel

Mallinckrodt Pharmaceuticals, USA

Jessica Valencia

Operational Excellence Expert

Novartis, USA

Vidhi Vashisht

Associate Director

Kinapse, India

Nirpal Virdee

Global Head, Transparency and Disclosure

Certara, UK

Thomas Wicks

Chief Strategy Officer

TrialScope

Julie Wood

Director of Strategy and Operations

Vivli, USA

Matthias Zerm, PhD

Lead Expert Clinical Trial Disclosure and R&D Processes, Global Clinical Development

Merz Pharmaceuticals GmbH, Germany